Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
종목 코드 SCNX
회사 이름Scienture Holdings Inc
상장일Feb 18, 2020
CEODr. Narasimhan Mani
직원 수14
유형Ordinary Share
회계 연도 종료Feb 18
주소- -
도시- -
증권 거래소NASDAQ Capital Market Consolidated
국가- -
우편 번호- -
전화- -
웹사이트- -
종목 코드 SCNX
상장일Feb 18, 2020
CEODr. Narasimhan Mani
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음